The latest medications recalled in the U.S., straight from the FDA's openFDA Enforcement database — what was recalled, why, and how serious it is. Informational only; for any product you have, follow the FDA's guidance and ask your pharmacist.
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
Haleon US Holdings LLC · Jun 4, 2026
Presence of Particulate matter: Particulate matter identified as glass.
SUN PHARMACEUTICAL INDUSTRIES INC · May 12, 2026
Presence of Particulate Matter.
B BRAUN MEDICAL INC · Apr 28, 2026
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Wisconsin Pharmacal Company · Apr 24, 2026
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
Amneal Pharmaceuticals, LLC · Mar 18, 2026
Non-Sterility: microbial contamination identified as Paenibacillus phoenicis
Cardinal Health 200, LLC · Mar 2, 2026
Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
McKesson · Jan 16, 2026
CGMP Deviations: product found to contain lead.
HANDELNINE GLOBAL LLC · Dec 22, 2025
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
StuffbyNainax · Dec 15, 2025
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Medinatura New Mexico, inc. · Dec 12, 2025
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Medinatura New Mexico, inc. · Dec 12, 2025
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Fresenius Kabi USA, LLC · Nov 6, 2025
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
Otsuka ICU Medical LLC · Oct 29, 2025
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
Otsuka ICU Medical LLC · Oct 29, 2025
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
ANTHONY TRINH, 123Herbals LLC · Oct 20, 2025
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Mohamed Hagar · Oct 8, 2025
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
IntegraDose Compounding Services LLC · Sep 16, 2025
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
Green Lumber Holdings, LLC · Aug 28, 2025
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Unichem Pharmaceuticals USA Inc. · Aug 27, 2025
Presence of Particulate Matter
B BRAUN MEDICAL INC · Aug 18, 2025
Presence of Particulate Matter.
B BRAUN MEDICAL INC · Aug 18, 2025
Microbial Contamination of Sterile Products: elevated endotoxin levels
GenoGenix LLC · Jul 30, 2025
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
DermaRite Industries, LLC · Jul 17, 2025
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
DermaRite Industries, LLC · Jul 17, 2025
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
DermaRite Industries, LLC · Jul 17, 2025
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
DermaRite Industries, LLC · Jul 17, 2025
Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million Unit
Sandoz Inc · Jun 27, 2025
Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin
Sandoz Inc · Jun 27, 2025
Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Church & Dwight Inc · Jun 6, 2025
Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Church & Dwight Inc · Jun 6, 2025
Microbial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
Church & Dwight Inc · Jun 6, 2025
Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Amneal Pharmaceuticals, LLC · Jun 2, 2025
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.
Umary-USA.com · May 21, 2025
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.
Umary-USA.com · May 21, 2025
Marketed without approved NDA/ANDA: The product has been found to be tainted with Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).
EnShiShiXiangNiShangMaoYouXianGongSi · May 6, 2025
Presence of Particulate Matter
Amneal Pharmaceuticals, LLC · Apr 17, 2025
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
SAINI TRADE INC · Apr 14, 2025
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
SAINI TRADE INC · Apr 14, 2025
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
SAINI TRADE INC · Apr 14, 2025
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
SAINI TRADE INC · Apr 14, 2025
Showing the 40 most recent Class I recalls of 1617 tracked.
Data source: U.S. FDA openFDA Drug Enforcement Reports. This page reproduces FDA recall data for reference and is not medical advice. Always follow the FDA's and your pharmacist's guidance.